Selected Advanced Solid Tumors research hub

Phase I/II, Multicenter, Open-label, Clinical and Pharmacokinetic Study of Lurbinectedin in Combination with Irinotecan in Pretreated Patients with Selected Advanced Solid Tumors

This study is testing a new combination of medicines, lurbinectedin and irinotecan, for people with advanced cancers that have already been treated. It aims to find the right dose and see how well it works and if it's safe.